Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Carmen s Biopharma
Entity

Carmen s Biopharma

Tracked across 1 events · 7 articles · First seen Mar 05, 2026 · Last active Mar 09, 2026

Sentiment
60
Attention
4
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 60
Tech
Cannabis Compounds Treat Fatty Liver Disease
Carmen s Biopharma, a U.S.-based biotechnology firm, has licensed the patent application from Hebrew University of Jerusalem for the use of Cannabidiol and Cannabigerol in metabolic conditions, aiming to advance the research toward clinical use.
Mar 05, 2026 · 7 articles
Relationships (1)
Hebrew University of Jerusalem licensee of ↔ Carmen s Biopharma Carmen s Biopharma licensed technology from Hebrew University of Jerusalem for m
NEWSDESK
Track Carmen s Biopharma live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.